Literature DB >> 2143916

Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation.

H Berglund1, S Boukter, E Theodorsson, H Vallin, O Edhag.   

Abstract

The aim of the present study was to determine whether left atrial size--a likely indicator of atrial stretching--correlates with the plasma concentration of atrial natriuretic peptide and whether this relation is different in patients in sinus rhythm and in those with atrial fibrillation. Arterial plasma concentrations of immunoreactive atrial natriuretic peptide (ir-ANP), adrenaline, noradrenaline, aldosterone, and vasopressin were measured in 13 patients in sinus rhythm without apparent heart failure and in 13 patients in atrial fibrillation. The two groups were matched for left atrial diameter and the ratio of the left atrial diameter to the diameter of the aortic root (assessed by echocardiography). There were no significant differences in age, heart rate, blood pressure, or left ventricular end diastolic diameter between the two groups. Left atrial diameters varied from 33 to 60 mm. The mean (SD) plasma concentration of ir-ANP was significantly higher (35 (21) pmol/l) in the patients with atrial fibrillation than in those in sinus rhythm (12 (11) pmol/l). The concentration of plasma aldosterone was also higher in patients with atrial fibrillation (831 (366) v 523 (211) pmol/l). Concentrations of adrenaline, noradrenaline, and vasopressin were similar in both groups. None of the hormone concentrations correlated with left atrial dimensions. These results indicate that plasma concentrations of ir-ANP and aldosterone are highly sensitive indicators of changes in haemodynamic function during atrial fibrillation. They also underscore the difficulties of correlating echocardiographic assessment of patients with plasma concentrations of a vasoactive hormone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143916      PMCID: PMC1024278          DOI: 10.1136/hrt.64.1.9

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  23 in total

1.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method.

Authors:  P Hjemdahl; M Daleskog; T Kahan
Journal:  Life Sci       Date:  1979-07-09       Impact factor: 5.037

2.  A radioimmunoassay for plasma aldosterone.

Authors:  D Mayes; S Furuyama; D C Kem; C A Nugent
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

3.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

Authors:  T B Levine; G S Francis; S R Goldsmith; A B Simon; J N Cohn
Journal:  Am J Cardiol       Date:  1982-05       Impact factor: 2.778

4.  A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection.

Authors:  H Hallman; L O Farnebo; B Hamberger; G Johnsson
Journal:  Life Sci       Date:  1978-09-11       Impact factor: 5.037

5.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

6.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

7.  Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up.

Authors:  S H Jacobson; O Eklöf; C G Eriksson; L E Lins; B Tidgren; J Winberg
Journal:  BMJ       Date:  1989-09-16

Review 8.  The relaxant effects of atrial natriuretic factor on vascular smooth muscle.

Authors:  R J Winquist
Journal:  Life Sci       Date:  1985-09-23       Impact factor: 5.037

9.  Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man.

Authors:  J V Anderson; A D Struthers; N N Payne; J D Slater; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1986-05       Impact factor: 6.124

10.  Nifedipine-induced renal dysfunction. Alterations in renal hemodynamics.

Authors:  J R Diamond; J Y Cheung; L S Fang
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

View more
  4 in total

1.  Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.

Authors:  I I Tulevski; M Groenink; E E van Der Wall; D J van Veldhuisen; F Boomsma; J Stoker; A Hirsch; J S Lemkes; B J Mulder
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

Review 2.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

3.  Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.

Authors:  H Berglund; O Nyquist; B Beermann; M Jensen-Urstad; E Theodorsson
Journal:  Br Heart J       Date:  1994-12

4.  Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.

Authors:  Marat Fudim; Peter R Liu; Peter Shrader; Rosalia G Blanco; Larry A Allen; Gregg C Fonarow; Bernard J Gersh; Peter R Kowey; Kenneth W Mahaffey; Elaine Hylek; Alan S Go; Laine Thomas; Eric D Peterson; Jonathan P Piccini
Journal:  J Am Heart Assoc       Date:  2018-04-13       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.